Posted on

What Caught Our Attention in the Investment World? – Week of September 6-9, 2022

By Kuldip K. Ambastha The stock of Regeneron Pharmaceuticals, Inc. (REGN), a biotechnology company with a portfolio of medicines for individuals with serious diseases, increased in price by +18.8% per share on the trading day of Thursday, September 8, 2022. Eylea (aka: aflibercept), an anti-blindness eye medication, was the cause of this price run-up, because …

Continue reading “What Caught Our Attention in the Investment World? – Week of September 6-9, 2022”

Posted on

What Caught Our Attention in the Investment World? – Week of February 15-19, 2021

By Kuldip K. Ambastha In the last few years, cryptocurrencies (and their associated blockchain technology usages) have attracted the attention of many investors. During the past trading week, the first-ever North American exchange-traded fund (ETF) for Bitcoin was launched. Purpose Bitcoin ETF (BTCC-B.TO) saw strong interest from investors and heavy daily trading volumes. Though cryptocurrencies …

Continue reading “What Caught Our Attention in the Investment World? – Week of February 15-19, 2021”

Posted on

What Caught Our Attention in the Investment World? – Week of December 2-6, 2019

By Kuldip K. Ambastha and Anil K. Ambastha On Thursday, December 5, 2019, there was “a tale of two cities,” to quote Charles Dickens. In the biotech arena, SAGE (Sage Therapeutics, Inc.) and AUPH (Aurinia Pharmaceuticals Inc.) were big movers. Sage Therapeutics delivered -59.7% for the day, while Aurinia Pharmaceuticals returned 78.8%. SAGE-217 is a …

Continue reading “What Caught Our Attention in the Investment World? – Week of December 2-6, 2019”